In 2018, a randomized controlled trial examining the effects of a 12-week KD in women with ovarian or endometrial cancer, demonstrated for the first time that KD is effective in promoting visceral fat loss, maintaining lean body mass, and decreasing cancer-related growth factors, such as insulin and IGF-1 [117]. The gene discussed is INS; the disease is endometrial cancer.